Aktuellt
A new study in collaboration with Statens Serum Institut and the University of Copenhagen, accepted for publication in the Journal of Virological Methods, documents 100% sensitivity for the NordicDx iaX platform – a powerful proof of concept for laboratory-grade quality in a rapid-test format.
Läs mer ->
Läs mer ->
The influenza outbreak is already underway in several places in Norway, and the Norwegian Institute of Public Health expects increased transmission in the coming weeks. At the same time, covid-19, RSV and other respiratory infections are circulating.
Läs mer ->
We are pleased to announce that NordicDx AS has achieved an extension of our accreditation under NS-EN ISO 15189. Effective from 4 November 2025, the Norwegian Accreditation Board has approved flexible accreditation scope for our measurement principles and analytical platforms in medical microbiology (M16).
Läs mer ->
This autumn we are seeing a clear increase in respiratory infections such as covid-19, influenza, RSV and the common cold. With home tests from NordicDx you can quickly get answers at home and make better decisions to protect yourself and others.
Läs mer ->
Stavanger: Analysis and biotechnology company NordicDx receives 7 million kroner from the Fisheries and Aquaculture Industry Research Funding (FHF) to develop a new, innovative rapid test for Listeria monocytogenes detection.
Läs mer ->
Looking for a pregnancy test that is reliable, easy to use and affordable? Then you've come to the right place! We offer Norway's best prices on quality pregnancy tests.
Läs mer ->
Tick bite? Test the tick at home! Tick bites can lead to Lyme disease (borreliosis), a serious infection caused by the borrelia bacterium.
Läs mer ->
At NordicDx, we believe in delivering excellence – and now, it's official. We proudly announce that NordicDx has officially received ISO 17025 and ISO 15189 accreditation.
Läs mer ->
We are proud to announce that our project has been awarded seed funding from HelseCampus Stavanger. This support gives us the opportunity to explore how Point-of-Care (POC) testing can improve decision-making in acute situations.
Läs mer ->
We are pleased to announce the successful finalisation of the BladderAI project, a collaboration between NordicDx and UroScan, co-funded by the EU DESIRE initiative.
Läs mer ->
Läs mer ->
Läs mer ->
Läs mer ->
Läs mer ->
